212 related articles for article (PubMed ID: 27043537)
1. The Expression Profile of Complement Components in Podocytes.
Li X; Ding F; Zhang X; Li B; Ding J
Int J Mol Sci; 2016 Mar; 17(4):471. PubMed ID: 27043537
[TBL] [Abstract][Full Text] [Related]
2. WT1-interacting protein and ZO-1 translocate into podocyte nuclei after puromycin aminonucleoside treatment.
Rico M; Mukherjee A; Konieczkowski M; Bruggeman LA; Miller RT; Khan S; Schelling JR; Sedor JR
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F431-41. PubMed ID: 15798086
[TBL] [Abstract][Full Text] [Related]
3. Complement expression in retinal pigment epithelial cells is modulated by activated macrophages.
Luo C; Zhao J; Madden A; Chen M; Xu H
Exp Eye Res; 2013 Jul; 112():93-101. PubMed ID: 23644095
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of nestin protects podocytes from apoptosis induced by puromycin aminonucleoside.
Wen D; You L; Zhang Q; Zhang L; Gu Y; Hao CM; Chen J
Am J Nephrol; 2011; 34(5):423-34. PubMed ID: 21952051
[TBL] [Abstract][Full Text] [Related]
5. A novel splicing variant of small nucleolar RNA host gene 4 is a podocyte-selective non-coding RNA upregulated in response to puromycin aminonucleoside-induced podocyte injury.
Horikawa A; Yoneda T; Yaoita E; Yamaguchi K; Shigenobu S; Kuramochi M; Yamate J; Inui T; Ishibashi O
J Biochem; 2019 May; 165(5):447-454. PubMed ID: 30597036
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of markers of podocyte injury in the rat puromycin aminonucleoside nephropathy model.
Kakimoto T; Okada K; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
Exp Toxicol Pathol; 2015 Feb; 67(2):171-7. PubMed ID: 25481214
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway.
Xiao H; Shi W; Liu S; Wang W; Zhang B; Zhang Y; Xu L; Liang X; Liang Y
Am J Nephrol; 2009; 30(1):34-43. PubMed ID: 19202327
[TBL] [Abstract][Full Text] [Related]
8. Hemicentin 1 influences podocyte dynamic changes in glomerular diseases.
Toffoli B; Zennaro C; Winkler C; Giordano Attianese GMP; Bernardi S; Carraro M; Gilardi F; Desvergne B
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1154-F1165. PubMed ID: 29488390
[TBL] [Abstract][Full Text] [Related]
9. The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis.
Wada T; Pippin JW; Terada Y; Shankland SJ
Kidney Int; 2005 Oct; 68(4):1618-29. PubMed ID: 16164639
[TBL] [Abstract][Full Text] [Related]
10. Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats.
Xiao HQ; Shi W; Liu SX; Zhang B; Xu LX; Liang XL; Liang YZ
Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):682-9. PubMed ID: 19594554
[TBL] [Abstract][Full Text] [Related]
11. Growth Hormone Induces Transforming Growth Factor-Beta-Induced Protein in Podocytes: Implications for Podocyte Depletion and Proteinuria.
Chitra PS; Swathi T; Sahay R; Reddy GB; Menon RK; Kumar PA
J Cell Biochem; 2015 Sep; 116(9):1947-56. PubMed ID: 25740786
[TBL] [Abstract][Full Text] [Related]
12. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
13. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
[TBL] [Abstract][Full Text] [Related]
14. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
Shibata S; Nagase M; Fujita T
J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
[TBL] [Abstract][Full Text] [Related]
15. Podocytes Produce and Secrete Functional Complement C3 and Complement Factor H.
Mühlig AK; Keir LS; Abt JC; Heidelbach HS; Horton R; Welsh GI; Meyer-Schwesinger C; Licht C; Coward RJ; Fester L; Saleem MA; Oh J
Front Immunol; 2020; 11():1833. PubMed ID: 32922395
[TBL] [Abstract][Full Text] [Related]
16. Newly identified cytoskeletal components are associated with dynamic changes of podocyte foot processes.
Miao J; Fan Q; Cui Q; Zhang H; Chen L; Wang S; Guan N; Guan Y; Ding J
Nephrol Dial Transplant; 2009 Nov; 24(11):3297-305. PubMed ID: 19617259
[TBL] [Abstract][Full Text] [Related]
17. Activation of a local tissue angiotensin system in podocytes by mechanical strain.
Durvasula RV; Petermann AT; Hiromura K; Blonski M; Pippin J; Mundel P; Pichler R; Griffin S; Couser WG; Shankland SJ
Kidney Int; 2004 Jan; 65(1):30-9. PubMed ID: 14675034
[TBL] [Abstract][Full Text] [Related]
18. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
Sonneveld R; van der Vlag J; Baltissen MP; Verkaart SA; Wetzels JF; Berden JH; Hoenderop JG; Nijenhuis T
Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445
[TBL] [Abstract][Full Text] [Related]
19. Puromycin aminonucleoside increases podocyte permeability by modulating ZO-1 in an oxidative stress-dependent manner.
Ha TS; Park HY; Seong SB; Ahn HY
Exp Cell Res; 2016 Jan; 340(1):139-49. PubMed ID: 26683996
[TBL] [Abstract][Full Text] [Related]
20. Influence of tacrolimus on podocyte injury inducted by angiotensin II.
Shengyou Y; Li Y; Zhihong H; Yuanyuan M
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):260-6. PubMed ID: 25650384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
